All clients

Spearheading a new paradigm for drug discovery.

Client
Generaregenerare.bio
Sector
Techbio
Scope
Brand & narrative strategy, identity, post-Series A launch & communication
Period
2026–ongoing

Context

Thirty years ago, pharma walked away from natural products, the molecules made by living organisms such as plants, fungi and bacteria. Generare introduces a cutting-edge method to explore that molecular chemistry at scale. How do you make it an essential player while the whole category is carried away by AI? By shifting the conversation, and putting the brand at the service of a new narrative.

Moment

  1. Grow

    Since February 2026

    From strategy and Brand Vault to the Series A launch narrative and media preparation, then character, voice and a new identity designed with Loïc Berger.

The core choice

Not a natural products company. Not another AI biotech. A data company mastering biology. Generating the novel molecular data no model has ever been trained on.

Generating the novel molecular data no model has ever been trained on.

Signature

Decoding what life wrote.

Life has been writing for three billion years. We've barely scratched the surface. Generare unearths, decodes and scales what life wrote.

Visual approach

The Generare logo over a petri dish rendered in pixels
The Generare wordmark over an opalescent texture
500: more than 500 FDA-approved drugs originate from microbial chemistry
Nature and its opalescent reading: an aerial landscape and moss, decoded
The Generare visual universe: nature, lab, molecules and pixels
A wall of molecules that came from nature
Decoding what life wrote: industrial-scale discovery of evolved molecules

Generare today

Ongoing partnership

Credits

Brand strategy & narrative by Grégoire Mulot & Enten-Eller.

Identity
Loïc Berger
Website
Jimmy Charles
Launch & PR management
Mathieu Daix